CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 6,040	$ 4,925
General and administrative	2,786	2,444
Total operating expenses	8,826	7,369
Loss from operations	(8,826)	(7,369)
Other income (expense):
Interest and other income	438	415
Interest and other expense	(81)	(185)
Loss before income taxes	(8,469)	(7,139)
Net loss and comprehensive loss	(8,469)	(7,139)
Other comprehensive loss:
Unrealized (loss) gain on investments, net	(45)	12
Comprehensive loss	$ (8,514)	$ (7,127)
Net loss per share, basic (in usd per share)	$ (0.29)	$ (0.42)
Net loss per share, diluted (in usd per share)	$ (0.29)	$ (0.42)
Weighted average shares used to compute basic net loss per share (in shares)	28,746,802	16,844,243
Weighted average shares used to compute diluted net loss per share (in shares)	28,746,802	16,844,243